摘要
目的:探讨非超声乳化水压法娩核术治疗老年性白内障的疗效及安全性。方法:选取2015年1月至2018年1月西安市北方医院收治的老年性白内障患者120例,依据随机数字表法分为娩核组和超声组,每组60例,超声组给予超声乳化术治疗,娩核组给予非超声乳化水压法娩核术治疗。结果:娩核组术后1 d、3 d、7 d最佳矫正视力、角膜内皮细胞密度明显高于超声组(P<0.05),两组术后1个月最佳矫正视力和角膜内皮细胞密度比较差异无统计学意义(P>0.05);娩核组术后1 d、3 d、7 d角膜散光度数、水肿程度明显低于超声组(P<0.05),两组术后1个月角膜散光度数、水肿程度比较差异无统计学意义(P>0.05);娩核组并发症率明显低于超声组(P<0.05)。结论:非超声乳化水压法娩核术可有效提高老年性白内障的早期疗效及安全性。
Objective:To discuss the efficacy and safety of non-phacoemulsification hydrostatic nucleus delivery in the treatment of senile cataract.Methods:120 patients with senile cataract were selected from January 2015 to January 2018 in our Hospital,according to the random distribution,all patients were divided into random digital table method,they were divided into the nucleus delivery group and the ultrasound group,ultrasound group was given phacoemulsification treatment,nucleus delivery group was given nonphacoemulsification hydrostatic nucleus delivery treatment.Results:The 1 d,3 d,7 d postoperative best corrected visual acuity and corneal endothelial cell density in the nucleus delivery group were significantly higher than those in the ultrasound group(P<0.05),there was no difference in the best corrected visual acuity and corneal endothelial cell density between the two groups at 1 month after operation(P>0.05).The 1 d,3 d,7 d postoperative corneal astigmatism and edema in the nucleus delivery group were significantly lower than those in the ultrasound group(P<0.05),there was no difference in the corneal astigmatism and edema between the two groups at 1 month after operation(P>0.05).The complication rate in the nucleus delivery group was significantly lower than that in the ultrasound group(P<0.05).Conclusion:Non phacoemulsification hydrostatic can effectively improve the early efficacy and safety of senile cataract.
作者
李雪
喻箭
LI Xue;YU Jian(Department of Ophthalmology,Xi'an Northern Hospital,Xi'an 710043,Shaanxi Province,P.R.C.)
出处
《中国数字医学》
2019年第10期10-12,共3页
China Digital Medicine
关键词
非超声乳化水压法娩核术
老年性白内障
疗效
安全性
non phacoemulsification hydrostatic nucleus delivery
senile cataract
efficacy
safety
